Press Releases

Press Releases

Aug 17, 2020
Phase 2b clinical trial in collaboration with Professor Shabir Madhi and Wits University Bill & Melinda Gates Foundation providing $15 million grant toward trial Mature trial infrastructure along with significant levels of seasonal transmission may allow for rapid efficacy evaluation GAITHERSBURG,...
Aug 10, 2020
Announced Positive Phase 1 data of Phase 1/2 clinical trial of NVX-CoV2373 Secured $2 billion in funding for global coronavirus vaccine program through CEPI, DoD , and OWS Expanded large scale global manufacturing capacity through acquisition and partnering Company to host conference call today at...
Aug 04, 2020
Phase 1 portion of the Phase 1/2 clinical trial evaluated two doses of Novavax’ COVID-19 vaccine across two dose levels (5 and 25 µg) in 131 healthy adults ages 18-59 years NVX-CoV2373 was generally well-tolerated and had a reassuring safety profile The vaccine induced neutralization titers in 100%...
Displaying 11 - 20 of 192